InflaRx (IFRX) Other Non-Current Liabilities (2016 - 2026)
InflaRx's (IFRX) quarterly Other Non-Current Liabilities came in at $42864.4 in Q2 2026, up 2.69% year-over-year from $41743.3 in Q2 2025, and down 0.72% quarter-over-quarter from $43173.6 in Q1 2026.
Analysis
InflaRx (IFRX) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends
InflaRx has disclosed Other Non-Current Liabilities across 11 years of filings, most recently posting $42864.4 for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities rose 2.69% year-over-year to $42864.4; the TTM figure through Jun 2026 stood at $42864.4 (up 2.69% YoY), while the FY2025 annual figure was $41664.0, up 5.73% from the prior year.
- Other Non-Current Liabilities came in at $42864.4 for Q2 2026 at InflaRx, down from $43173.6 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $43173.6 in Q1 2026 to a low of $37623.7 in Q4 2022.
- Average Other Non-Current Liabilities over 5 years is $40551.7, with a median of $40150.1 recorded in 2023.
- Year-over-year, Other Non-Current Liabilities dropped 6.08% in 2022 and rose 11.3% in 2026.
- Over 5 years, Other Non-Current Liabilities stood at $37623.7 in 2022, then climbed by 5.46% to $39677.4 in 2023, then dropped by 0.68% to $39406.6 in 2024, then increased by 8.93% to $42926.4 in 2025, then dropped by 0.14% to $42864.4 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $42864.4 in Q2 2026, $43173.6 in Q1 2026, and $42926.4 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42,864.42 |
| Mar 31, 2026 | 43,173.59 |
| Dec 31, 2025 | 42,926.43 |
| Sep 30, 2025 | 43,111.24 |
| Jun 30, 2025 | 41,743.28 |
| Mar 31, 2025 | 38,790.34 |
| Dec 31, 2024 | 39,406.59 |
| Sep 30, 2024 | 40,499.04 |
| Jun 30, 2024 | 39,712.38 |
| Mar 31, 2024 | 40,061.76 |
| Dec 31, 2023 | 39,677.44 |
| Sep 30, 2023 | 40,143.95 |
| Jun 30, 2023 | 40,156.26 |
| Mar 31, 2023 | 39,581.63 |
| Dec 31, 2022 | 37,623.66 |
| Sep 30, 2022 | 40,208.97 |
| Jun 30, 2022 | 40,263.25 |
| Mar 31, 2022 | 39,986.65 |
| Dec 31, 2021 | 40,060.72 |
| Sep 30, 2021 | 41,003.82 |